Enanta Pharmaceuticals Inc (NASDAQ: ENTA) stock enjoyed a major increase of 13.8% on 1/4/24. The shares closed at $12.04. Moreover, trading volume in this advance was exceptionally high at 267% of normal. The stock has been extremely weak relative to the market over the last nine months but has risen 27.4% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, ENTA is expected to continue to be Value Creation neutral.
Enanta Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Enanta Pharmaceuticals has a poor Appreciation Score of 24 and a very low Power Rating of 10, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment